|
MYO1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.33990000001405E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55698999999565E-05 |
| Normal-vs-Stage2 |
4.350300E-04 |
| Normal-vs-Stage3 |
1.293900E-02 |
| Normal-vs-Stage4 |
3.983400E-01 |
| Stage1-vs-Stage2 |
9.999400E-01 |
| Stage1-vs-Stage3 |
1.605820E-01 |
| Stage1-vs-Stage4 |
1.843770E-01 |
| Stage2-vs-Stage3 |
2.505000E-01 |
| Stage2-vs-Stage4 |
8.991600E-02 |
| Stage3-vs-Stage4 |
3.692400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.75440000036187E-07 |
| Normal-vs-AfricanAmerican |
4.322700E-03 |
| Normal-vs-Asian |
4.247900E-02 |
| Caucasian-vs-AfricanAmerican |
2.257200E-01 |
| Caucasian-vs-Asian |
7.772200E-01 |
| AfricanAmerican-vs-Asian |
8.910000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8012999980499E-08 |
| Normal-vs-Female |
7.536000E-02 |
| Male-vs-Female |
6.11419999999585E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.082400E-03 |
| Normal-vs-Extreme_Weight |
2.94649971088745E-10 |
| Normal-vs-Obese |
1.320150E-02 |
| Normal-vs-Extreme_Obese |
2.476200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.026230E-01 |
| Normal_Weight-vs-Obese |
7.752200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.679000E-01 |
| Extreme_Weight-vs-Obese |
6.002100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.286800E-01 |
| Obese-vs-Extreme_Obese |
9.883600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.364600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.0876000000003E-05 |
| Normal-vs-Age(61-80Yrs) |
1.14910000004187E-06 |
| Normal-vs-Age(81-100Yrs) |
7.41539996074181E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.433600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.824590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.729600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.211600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.262900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.470400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.69517741458003E-12 |
| Normal-VS-Type2 PRCC |
8.001600E-03 |
| Normal-VS-KIRP CIMP |
1.020480E-02 |
| Normal-VS-Unclassified PRCC |
2.33309999997378E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.601620E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.87294624254264E-13 |
| Type1 PRCC-VS-Unclassified PRCC |
2.798600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.025300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.642200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.43050000523237E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.49259999810059E-08 |
| Normal-vs-N1 |
6.023800E-01 |
| Normal-vs-N2 |
3.014600E-01 |
| N0-vs-N1 |
6.36869999999234E-05 |
| N0-vs-N2 |
1.215960E-01 |
| N1-vs-N2 |
5.916200E-01 |
|
|
